Pulse Biosciences, Inc. PLSE
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -24.66M | -18.58M | -17.43M | -19.39M | -19.17M |
| Total Depreciation and Amortization | 254.00K | 255.00K | 259.00K | 256.00K | 273.00K |
| Total Amortization of Deferred Charges | 0.00 | 281.00K | -- | -- | -- |
| Total Other Non-Cash Items | 5.30M | 2.28M | 6.12M | 5.62M | 5.47M |
| Change in Net Operating Assets | 392.00K | 1.17M | -3.70M | 473.00K | 617.00K |
| Cash from Operations | -18.71M | -14.60M | -14.76M | -13.04M | -12.81M |
| Capital Expenditure | -90.00K | -33.00K | -105.00K | -62.00K | -103.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 0.00 | -20.00K |
| Cash from Investing | -90.00K | -33.00K | -105.00K | -62.00K | -123.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 52.04M | 2.27M | 381.00K | 1.97M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 57.00K | -57.00K | -- | -- | -- |
| Cash from Financing | 52.10M | 2.21M | 381.00K | 1.97M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 33.30M | -12.42M | -14.48M | -11.14M | -12.93M |